Literature DB >> 9311903

The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation.

C Browning1, J M Hilfinger, S Rainier, V Lin, S Hedderwick, M Smith, D M Markovitz.   

Abstract

Human immunodeficiency virus type 2 (HIV-2) causes AIDS, but generally after a much longer asymptomatic period than that which follows infection with HIV-1. At the molecular level, HIV-2 is much more closely related to the simian immunodeficiency viruses than to HIV-1 and our previous studies have demonstrated that HIV-2 and HIV-1 enhancer stimulation is mediated by different sets of cellular proteins following T-cell activation. Similar to HIV-1, HIV-2 encodes a transactivating protein, Tat, which appears to be necessary for viral replication and stimulates viral transcriptional initiation and/or elongation. While Tat-1 binds to the RNA of the trans-activation responsive (TAR) region of HIV-1 and HIV-2, cellular factors that bind to the RNA transcript are also necessary for Tat to function in vivo. Since almost all previous investigations of cellular cofactors for Tat had focused on HIV-1, we undertook studies aimed at understanding the interaction between the TAR RNA region of the HIV-2 promoter (TAR-2) and cellular proteins. By using extension inhibition analysis (toeprinting) and RNA electrophoretic mobility shift assays, we demonstrated binding of a nuclear factor(s) in T cells to the base of the promoter-proximal stem-loop structure. Mutational analysis of this region revealed that both the sequence of the 3' arm and the stem structure itself are important for activation of the promoter by Tat-2. In contrast, the structure is necessary for activation of TAR-2 by Tat-1 but the sequence is less important. These results suggest that a cellular factor interacts with the 3' arm of the proximal stem-loop structure of TAR-2 and mediates Tat-2-induced increases in the level of HIV-2 transcripts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311903      PMCID: PMC192170          DOI: 10.1128/JVI.71.10.8048-8055.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  An improved T1/A ribonuclease protection assay.

Authors:  M Bordonaro; C F Saccomanno; J L Nordstrom
Journal:  Biotechniques       Date:  1994-03       Impact factor: 1.993

2.  The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.

Authors:  K Rittner; M J Churcher; M J Gait; J Karn
Journal:  J Mol Biol       Date:  1995-05-05       Impact factor: 5.469

3.  Transcriptional elongation by RNA polymerase II is stimulated by transactivators.

Authors:  K Yankulov; J Blau; T Purton; S Roberts; D L Bentley
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

4.  HIV-1 Tat protein is able to efficiently transactivate the HIV-2 LTR through a TAR RNA element lacking both dinucleotide bulge binding sites.

Authors:  H Rhim; A P Rice
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

5.  Direct interactions between autoantigen La and human immunodeficiency virus leader RNA.

Authors:  Y N Chang; D J Kenan; J D Keene; A Gatignol; K T Jeang
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNA.

Authors:  Y V Svitkin; A Pause; N Sonenberg
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Natural protection against HIV-1 infection provided by HIV-2.

Authors:  K Travers; S Mboup; R Marlink; A Guèye-Nidaye; T Siby; I Thior; I Traore; A Dieng-Sarr; J L Sankalé; C Mullins
Journal:  Science       Date:  1995-06-16       Impact factor: 47.728

8.  Identification of a novel HIV-1 TAR RNA bulge binding protein.

Authors:  B Baker; M Muckenthaler; E Vives; A Blanchard; M Braddock; W Nacken; A J Kingsman; S M Kingsman
Journal:  Nucleic Acids Res       Date:  1994-08-25       Impact factor: 16.971

9.  Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1).

Authors:  C A Kozak; A Gatignol; K Graham; K T Jeang; O W McBride
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

10.  Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.

Authors:  S H Ou; F Wu; D Harrich; L F García-Martínez; R B Gaynor
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  3 in total

1.  Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy.

Authors:  C M Browning; L Cagnon; P D Good; J Rossi; D R Engelke; D M Markovitz
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  GLI-2 modulates retroviral gene expression.

Authors:  M J Smith; S D Gitlin; C M Browning; B R Lane; N M Clark; N Shah; S Rainier; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Human GLI-2 is a tat activation response element-independent Tat cofactor.

Authors:  C M Browning; M J Smith; N M Clark; B R Lane; C Parada; M Montano; V N KewalRamani; D R Littman; M Essex; R G Roeder; D M Markovitz
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.